← FDA Drug Approvals (Drugs@FDA)

CASSIPA

NDA · New Drug Application · Sponsor: TEVA PHARMS USA · Approved 2018-09-07

Drug application

FDA Application #

NDA208042

Application type

New Drug Application

Brand name

CASSIPA

Generic name

Buprenorphine Hydrochloride

Active ingredients

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Dosage form

FILM

Route

SUBLINGUAL

Marketing status

Discontinued

Sponsor

TEVA PHARMS USA

First approval

2018-09-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown